Genetic Technologies Limited
GENE · NASDAQ
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,598 | -$6,419 | $0 | -$5,460 |
| Dep. & Amort. | $254 | $281 | $0 | $330 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $124 | $0 | $0 | $0 |
| Change in WC | -$31 | $0 | $0 | $0 |
| Other Non-Cash | -$416 | $2,243 | -$3,591 | $2,407 |
| Operating Cash Flow | -$5,667 | -$3,896 | -$3,479 | -$2,724 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$7 | -$13 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | -$0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $30 | $118 | $192 | $80 |
| Investing Cash Flow | $25 | -$7 | $179 | $79 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$173 | -$336 | -$166 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,997 | -$2 | -$64 | $0 |
| Financing Cash Flow | $2,997 | -$173 | -$400 | -$166 |
| Forex Effect | -$64 | -$29 | $67 | -$89 |
| Net Chg. in Cash | -$3,729 | -$1,169 | -$2,630 | -$2,900 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,729 | $4,898 | $10,481 | $7,945 |
| End Cash | $0 | $3,729 | $7,851 | $5,045 |
| Free Cash Flow | -$5,672 | -$3,903 | -$2,487 | -$2,724 |